Stellantis N.V. Company Profile, 2024: Business Model, SWOT, M&A Activity, Strategic Partnerships, and Latest Developments with Data-Driven Insights
June 05, 2024 10:51 ET
|
Research and Markets
Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "Stellantis N.V. - Company Profile and SWOT Analysis" swot analysis has been added to ResearchAndMarkets.com's offering.Stellantis N.V. - Company...
VPS AI Announces Strategic Partnership with Taiko: Ushering in a New Era of Blockchain Technology
June 05, 2024 10:51 ET
|
VPS AI
NEW YORK, NY, June 05, 2024 (GLOBE NEWSWIRE) -- In a landmark move, VPS AI has proudly announced the successful deployment of the first Validator Node for the Taiko Blockchain. This partnership...
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Globe Life Inc. with Losses to Contact the Firm
June 05, 2024 10:50 ET
|
Schall Law
The Schall Law Firm Encourages Investors in Globe Life Inc. with Losses to Contact the Firm
AMC Entertainment Holdings, Inc. - Company Profile, SWOT Analysis, and a 5-Year Review of Deal Activity
June 05, 2024 10:48 ET
|
Research and Markets
Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "AMC Entertainment Holdings, Inc. - Company Profile and SWOT Analysis" swot analysis has been added to ResearchAndMarkets.com's offering.This profile...
Late Breaking Poster Shows a Novel Oral Insulin Sensitizer Azemiglitazone (MSDC-0602K) Could Substantially Preserve Lean Muscle in Combination with Weight-Loss GLP1s
June 05, 2024 10:48 ET
|
Cirius Therapeutics
Azemiglitazone (MSDC-0602K) working through a newly identified mitochondrial target adds cardiometabolic benefit to GLP-1 receptor agonists Benefit includes preservation of lean muscle, which could...
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sharecare
June 05, 2024 10:45 ET
|
Faruqi & Faruqi LLP
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sharecare, Inc. (“Sharecare” or the “Company”)...
BST Global Appoints Eileen M. Canady as Chief Marketing Officer to Spearhead Growth & Brand Innovation in the AEC Industry
June 05, 2024 10:41 ET
|
BST Global
Tampa, FL, USA, June 05, 2024 (GLOBE NEWSWIRE) -- BST Global, a provider of AI-powered project intelligence™ solutions for the architecture, engineering and consulting (AEC) industry, announced the...
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
June 05, 2024 10:40 ET
|
Faruqi & Faruqi LLP
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ocugen, Inc. (“Ocugen” or the “Company”)...
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Malibu Boats, Inc. with Losses to Contact the Firm
June 05, 2024 10:40 ET
|
Schall Law
The Schall Law Firm Encourages Investors in Malibu Boats, Inc. with Losses to Contact the Firm
RYBREVANT®▼ (amivantamab) más lazertinib muestra una mayor supervivencia libre de progresión en comparación con osimertinib en el tratamiento en primera línea en pacientes con cáncer de pulmón no microcítico de alto riesgo con mutación del EGFR
June 05, 2024 10:38 ET
|
Janssen Cilag International NV
El régimen sin quimioterapia en investigación de amivantamab más lazertinib aborda una importante necesidad no cubierta puesto que la mayoría de los pacientes con CPNM con mutación del EGFR tiene...